Latest Regulatory News

Michael Hill International reported a steady FY25 with revenue holding firm at $643.7 million and a return to profitability despite ongoing retail challenges. The year saw strategic store closures, digital sales growth, and leadership changes, setting the stage for a reset under new CEO Jonathan Waecker.

Haranga Resources has secured regulatory approvals and begun underground works at its Lincoln Gold Project, setting the stage for a maiden drilling campaign aimed at upgrading a significant historical gold resource to JORC standards.

LTR Pharma’s SPONTAN nasal spray has achieved unanimous patient satisfaction in treating erectile dysfunction after prostate surgery, signaling a promising shift in therapy preferences.

Decidr AI Industries has agreed to acquire the remaining 49% stake in Decidr.ai, issuing 78.4 million shares to complete full ownership and accelerate its AI platform integration.

Piedmont Lithium Inc. has halted trading on the ASX as it finalises a merger with Sayona Mining Limited, marking a significant restructuring in the lithium mining sector.

DATA#3 Limited has announced a fully franked ordinary dividend of AUD 0.15 per share for the six months ending June 2025, signaling steady shareholder returns amid a stable financial period.

Endeavour Group reported a slight revenue decline and a 16% drop in profit for FY25, alongside significant leadership changes including the appointment of a new CEO. The company is advancing its technology separation and sustainability initiatives while maintaining dividend payments.

Sayona Mining has significantly increased the Mineral Resource and Ore Reserves at its Moblan Lithium Project in Quebec, reinforcing the project's long-term viability amid rising lithium demand.

Regis Healthcare reported robust FY25 financial results, driven by increased occupancy, strategic acquisitions, and a strong balance sheet, positioning itself well ahead of the new Aged Care Act reforms.

Magnetite Mines Limited faces immediate suspension of its MGTOF securities from ASX quotation due to non-compliance with listing rules, raising questions about regulatory hurdles ahead.

Regis Healthcare has reported a robust FY25 financial performance, marked by significant profit growth and strategic acquisitions, positioning itself for ambitious expansion in Australia’s aged care sector.

Regis Healthcare delivered a robust FY25 performance with a 14.5% revenue increase and a dramatic turnaround to a $49 million net profit. The company is advancing growth through acquisitions and greenfield developments, positioning itself strongly ahead of upcoming sector reforms.